The Effect of Ganoderma on Patients With Head-and-neck Cancer

Head-and-neck Cancer Clinical Trial

Official title: The Effect of Gandoerma Spores Powder Capsules on the Post-treatment Life Quality and Immune Modulation of the Patients With Head-and-neck Cancer

Status Recruiting

Clinical Trial Summary

To study the effect of Ganoderma Spores Powder Capsules on the life quality and immunity status of the patients with head-and-neck cancer after complete treatment (including surgery and / or radiotherapy and/or chemotherapy)

Clinical Trial Description

Ganoderma is known to modulate immunity and improve health. However, the mechanism is not clear. We hypothesize that patients who have completed standard treatment with/without radiotherapy might require biological modifier such as Ganoderma to improve life quality and immunity status.

A total of 100 patients are randomized to study and control groups. In study group, Ganoderma Spores Powder Capsules are given to the patients for 6 weeks, In control group, only placebos are given during the same period. Then the patients in study and control groups are switched, Ganoderma Spores Powder Capsules and placebos are given for 6 weeks. The data pertaining to their Life quality are collected using Quality of Life Questionnaire after the first 6 weeks and the second 6 weeks. The immunity status is also studied at the same time. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor)

Related Conditions & MeSH terms

• Head and Neck Neoplasms
• Head-and-neck Cancer

• NCT number: NCT02238587
• Study type: Interventional
• Source: Chang Bing Show Chwan Memorial Hospital
• Contact: Ching-Yeh Hsiung
• Phone: 886-975617327
• Email: hsiungcy@hotmail.com
• Status: Recruiting
• Phase: N/A
• Start date: June 2014
• Completion date: May 2015